As GSH levels are altered in pulmonary diseases such as idiopathic pulmonary fibrosis and that Grx1 has the ability to reduce S-glutathionylated proteins, studies using recombinant Grx1 administration have gained a special attention in the redox field. Here, GLRX is linked to lung disorder.